Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 28, 2020; 26(48): 7619-7632
Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7619
Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7619
Figure 2 Intestinal trefoil factor promoted the proliferation and migration and inhibited necrosis of GES-1 cells.
A: Intestinal trefoil factor (ITF) promoted proliferation of GES-1 cells, and LY294002 decreased the cell viability; B: Fluorescent images of treated cells following fluorescein diacetate (FDA)/propidium iodide (PI) staining. Viable cells were stained with FDA (green), and necrotic cells were stained with propidium iodide (red), the scale bar = 200 μm; C: Transwell migration; and D: Wound healing assay analyzed the migration of GES-1 cells treated with lipopolysaccharides (LPS), ITF, or LY294002. The images are representative of three independent experiments; aP < 0.05 vs control cells; bP < 0.05 vs LPS-treated cells.
- Citation: Huang Y, Wang MM, Yang ZZ, Ren Y, Zhang W, Sun ZR, Nie SN. Pretreatment with intestinal trefoil factor alleviates stress-induced gastric mucosal damage via Akt signaling. World J Gastroenterol 2020; 26(48): 7619-7632
- URL: https://www.wjgnet.com/1007-9327/full/v26/i48/7619.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i48.7619